Karnataka Antibiotics & Pharmaceuticals

What Karnataka Antibiotics & Pharmaceuticals does

Karnataka Antibiotics & Pharmaceuticals Limited (KAPL) is a Central Pharma Public Sector Undertaking established on 13 March 1981 as a joint sector company between the Government of India (59.17% shareholding) and the Government of Karnataka through KSIIDC (40.83%), operating under the Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals. The company manufactures and supplies affordable pharmaceutical products across four verticals: human pharmaceuticals (antibiotics including penicillins and cephalosporins, analgesics, cardiovascular, gastrointestinal, antihistamines, multivitamins), veterinary products (antibiotics, anthelmintics, ectoparasiticides, feed supplements for livestock and poultry), agro products (bio-stimulants, crop protection formulations), and Ayurvedic formulations (hepatoprotectives, cough syrups, antidiarrhoeals, joint pain management).

Operations are anchored at two manufacturing facilities — the main factory at Peenya Industrial Area, Bangalore and the Ayush Plant at Dharwad, Karnataka — supported by 19 branch offices across India organized into South-West and North-East regional structures. KAPL operates GMP-compliant manufacturing across multiple dosage forms (Dry Powder Parenteral, Small Volume Parenteral, tablets, capsules, liquid orals, dry syrups, sachets, and powders), with ISO 9001:2008 certification and NABL-accredited quality testing. The company has recorded continuous profitability since inception.

Revenue is generated through two principal channels: (i) institutional/government supply of essential medicines and life-saving drugs to public hospitals, healthcare programs, and procurement systems including GeM and state e-procurement portals, and (ii) private trade market sales via a direct field sales force of regional and area managers. Authorized capital is Rs. 15 crores with paid-up capital of Rs. 13.49 crores; the company is not publicly traded. Recognition includes the India Pharma Swachhata Champion Award 2020 from the Ministry of Chemicals & Fertilizers and an Export Award.

Name

Karnataka Antibiotics & Pharmaceuticals

Legal name

KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED

Website

https://kaplindia.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

501–1,000 employees

Short description

KAPL is a government-owned pharmaceutical PSU manufacturing affordable human, veterinary, agro, and Ayurvedic medicines across India via two manufacturing facilities and 19 branch offices, supplying government healthcare programs and private trade channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical manufacturing
• Antibiotics production
• Veterinary medicines
• Ayurvedic formulations
• Agro chemicals

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and sale of pharmaceutical products including human drugs, veterinary medicines, agro products, and Ayurvedic formulations through direct sales force and government supply channels.
2. Government Healthcare Supply: Supply of essential medicines and life-saving drugs to government hospitals, healthcare programs, and institutional buyers as a Central Pharma Public Sector Undertaking.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Karnataka Antibiotics & Pharmaceuticals Limited (KAPL) is a government-owned pharmaceutical manufacturer producing a diversified portfolio across human pharmaceuticals (antibiotics, analgesics, cardiovascular and gastrointestinal drugs), veterinary medicines (anthelmintics, antibiotics, feed supplements), agro products (bio-stimulants, crop protection), and Ayurvedic formulations. The company operates GMP-compliant manufacturing facilities producing Dry Powder Parenteral, Small Volume Parenteral, Tablets, Capsules, Liquid Orals, Dry Syrups, Sachets, and Powders, supplying medicines at affordable prices primarily to government healthcare programs and the private trade market across India.

Product overview

Karnataka Antibiotics & Pharmaceuticals Limited (KAPL) is a government-owned pharmaceutical company manufacturing a diversified portfolio of pharmaceutical products and offering contract manufacturing services. The company operates across four main product categories: Human Pharma (antibiotics, analgesics, cardiovascular, gastrointestinal medications), Veterinary Products (antibiotics, anthelmintics, feed supplements), Agro Products (bio-stimulants, crop protection), and Ayurvedic Products (herbal formulations). KAPL provides manufacturing services through specialized facilities for dry powder parenterals, small volume parenterals, tablets, capsules, liquid orals, dry syrups, sachets, and powders, all operating under GMP standards with quality assurance and R&D support.

Differentiator

Problem solved

Functional benefit

Products and services

• Human Pharmaceutical Products Comprehensive range of human pharmaceutical products including antibiotics (penicillins, cephalosporins), analgesics, cardiovascular drugs, gastrointestinal medications, antihistamines, and multivitamins across tablets, capsules, syrups, and injectable formats. Targeted at government hospitals, healthcare institutions, and the retail pharmacy market.
• Veterinary Pharmaceutical Products Veterinary product line including antibiotics, anthelmintics, ectoparasiticides, multivitamins, liver tonics, and feed supplements for livestock (cattle, buffalo, sheep, goat, pig, horse) and poultry. Targeted at livestock and poultry farmers.
• Agro Products Agricultural product range including bio-stimulants, foliar sprays, and crop protection products for agricultural and horticultural crops. Targeted at farmers and agricultural users.
• Ayurvedic Products Ayurvedic formulations including hepatoprotectives, cough syrups, antidiarrhoeals, antacids, laxatives, and joint pain management products based on traditional Ayurvedic ingredients combined with modern pharmaceutical standards. Targeted at consumers seeking herbal healthcare alternatives.
• Oxytocin Oxytocin injection for maternal and child healthcare, used to stimulate uterine contractions for facilitating parturition and promote milk let-down in animals. Targeted at hospitals and veterinary users.

Quantifiable outcome

• Consistent profitability since company inception in 1981
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Indian Drugs & Pharmaceuticals Limited (IDPL): Central Pharma PSU historically focused on essential medicines and formulations. Directly comparable to KAPL in government ownership, essential-medicines mandate, and multi-dosage-form manufacturing footprint.
• Hindustan Antibiotics Limited: Another Central Pharma PSU under the Department of Pharmaceuticals, focused on antibiotic and life-saving drug manufacturing. Closely comparable to KAPL in ownership structure, government-mandated mission, and core antibiotic/essential-medicines portfolio.
• Rajasthan Drugs & Pharmaceuticals Limited: Joint sector PSU pharma company manufacturing formulations and dosage forms. Closely comparable to KAPL as a state-level joint venture pharma manufacturer with government supply mandates.
• Bengal Chemicals & Pharmaceuticals Limited: Government of India PSU pharma manufacturer producing pharmaceuticals, chemicals, and cosmetics. Directly comparable to KAPL as a fellow Central Pharma PSU with a diversified portfolio and government-mandated affordable-medicines focus.

Regional players

• TTK Healthcare Limited: Indian mid-size pharma manufacturer with diverse product portfolio including human pharma, veterinary, and consumer health. Comparable to KAPL in diversified dosage-form manufacturing and Indian market focus, though privately held.
• Granules India Limited: Indian pharma manufacturer with focus on formulations, APIs, and finished dosages including paracetamol and similar mass-market drugs. Comparable to KAPL in affordable-medicine positioning and Indian domestic market focus.
• Morepen Laboratories Limited: Indian generic pharmaceutical manufacturer with API and finished dosage capabilities. Comparable to KAPL in generic formulation focus and Indian market presence, with similar mid-scale manufacturing operations.

Broad incumbents

• Cipla Limited: Major Indian multinational pharma company with strong portfolio in antibiotics, respiratory, and essential medicines. Overlaps with KAPL in antibiotic and primary care therapeutic categories and government healthcare supply.
• Sun Pharmaceutical Industries Limited: India's largest pharmaceutical company with broad generics and specialty portfolio. Comparable in generic manufacturing and Indian hospital/retail distribution, though operating at far greater scale and with global footprint.
• Aurobindo Pharma Limited: One of India's largest generic pharmaceutical manufacturers with broad product portfolio and global operations. Overlaps with KAPL in generic formulations, antibiotic manufacturing, and government hospital supply, though at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/kapl_bangalore
• Facebookfacebook.com/KAPLHOBANGALORE

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karnataka Antibiotics & Pharmaceuticals